» Articles » PMID: 8256857

Survey of the Distribution of a Newly Characterized Receptor for Advanced Glycation End Products in Tissues

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 1993 Dec 1
PMID 8256857
Citations 266
Authors
Affiliations
Soon will be listed here.
Abstract

Advanced glycation end products (AGEs), the final products of nonenzymatic glycation and oxidation of proteins, are found in the plasma and accumulate in the tissues during aging and at an accelerated rate in diabetes. A novel integral membrane protein, termed receptor for AGE (RAGE), forms a central part of the cell surface binding site for AGEs. Using monospecific, polyclonal antibody raised to human recombinant and bovine RAGE, immunostaining of bovine tissues showed RAGE in the vasculature, endothelium, and smooth muscle cells and in mononuclear cells in the tissues. Consistent with these data, RAGE antigen and mRNA were identified in cultured bovine endothelium, vascular smooth muscle, and monocyte-derived macrophages. RAGE antigen was also visualized in bovine cardiac myocytes as well as in cultures of neonatal rat cardiac myocytes and in neural tissue where motor neurons, peripheral nerves, and a population of cortical neurons were positive. In situ hybridization confirmed the presence of RAGE mRNA in the tissues, and studies with rat PC12 pheochromocytes indicated that they provide a neuronal-related cell culture model for examining RAGE expression. Pathological studies of human atherosclerotic plaques showed infiltration of RAGE-expressing cells in the expanded intima. These results indicate that RAGE is present in multiple tissues and suggest the potential relevance of AGE-RAGE interactions for modulating properties of the vasculature as well as neural and cardiac function, prominent areas of involvement in diabetes and in the normal aging process.

Citing Articles

Resveratrol Attenuates Fibrosis and Alters Signaling Pathways in Diabetic Cardiac and Skeletal Muscles and Adipose Tissue Without Reversing Structural Damage.

Strunz C, Roggerio A, Cruz P, Benvenuti L, Irigoyen M, Mansur A Int J Mol Sci. 2025; 26(4).

PMID: 40004135 PMC: 11855909. DOI: 10.3390/ijms26041672.


Peripheral blood miRNAs are associated with airflow below threshold in children with asthma.

Tiwari A, Hobbs B, Sharma R, Li J, Kho A, Amr S Respir Res. 2025; 26(1):38.

PMID: 39856653 PMC: 11763123. DOI: 10.1186/s12931-025-03116-w.


Role of the Receptor for Advanced Glycation End Products (RAGE) and Its Ligands in Inflammatory Responses.

Cross K, Vetter S, Alam Y, Hasan M, Nath A, Leclerc E Biomolecules. 2025; 14(12.

PMID: 39766257 PMC: 11673996. DOI: 10.3390/biom14121550.


Role of the receptor for advanced glycation end products in the severity of SARS-CoV-2 infection in diabetic patients.

Pedreanez A, Mosquera-Sulbaran J, Tene D Diabetol Int. 2024; 15(4):732-744.

PMID: 39469543 PMC: 11512988. DOI: 10.1007/s13340-024-00746-1.


Cutaneous adaptive immunity and uraemia: a narrative review.

Zibandeh N, Li Z, Ogg G, Bottomley M Front Immunol. 2024; 15:1464338.

PMID: 39399503 PMC: 11466824. DOI: 10.3389/fimmu.2024.1464338.


References
1.
Lau Y, Robinson R, Rosen M, Bilezikian J . Subclassification of beta-adrenergic receptors in cultured rat cardiac myoblasts and fibroblasts. Circ Res. 1980; 47(1):41-8. DOI: 10.1161/01.res.47.1.41. View

2.
Schmidt A, Yan S, Brett J, Mora R, Nowygrod R, Stern D . Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. J Clin Invest. 1993; 91(5):2155-68. PMC: 288218. DOI: 10.1172/JCI116442. View

3.
Furie M, Cramer E, Naprstek B, Silverstein S . Cultured endothelial cell monolayers that restrict the transendothelial passage of macromolecules and electrical current. J Cell Biol. 1984; 98(3):1033-41. PMC: 2113155. DOI: 10.1083/jcb.98.3.1033. View

4.
Gown A, Vogel A, Gordon D, Lu P . A smooth muscle-specific monoclonal antibody recognizes smooth muscle actin isozymes. J Cell Biol. 1985; 100(3):807-13. PMC: 2113501. DOI: 10.1083/jcb.100.3.807. View

5.
Greene L, Aletta J, Rukenstein A, Green S . PC12 pheochromocytoma cells: culture, nerve growth factor treatment, and experimental exploitation. Methods Enzymol. 1987; 147:207-16. DOI: 10.1016/0076-6879(87)47111-5. View